4MAO image
Deposition Date 2013-08-16
Release Date 2014-10-22
Last Version Date 2024-11-06
Entry Detail
PDB ID:
4MAO
Title:
RSK2 T493M C-Terminal Kinase Domain in Complex with RMM58
Biological Source:
Source Organism:
Mus musculus (Taxon ID: 10090)
Host Organism:
Method Details:
Experimental Method:
Resolution:
2.60 Å
R-Value Free:
0.29
R-Value Work:
0.23
R-Value Observed:
0.23
Space Group:
P 41 21 2
Macromolecular Entities
Polymer Type:polypeptide(L)
Molecule:Ribosomal protein S6 kinase alpha-3
Gene (Uniprot):Rps6ka3
Mutations:T493M, K591E
Chain IDs:A
Chain Length:355
Number of Molecules:1
Biological Source:Mus musculus
Primary Citation
Design of reversible, cysteine-targeted Michael acceptors guided by kinetic and computational analysis.
J.Am.Chem.Soc. 136 12624 12630 (2014)
PMID: 25153195 DOI: 10.1021/ja505194w

Abstact

Electrophilic probes that covalently modify a cysteine thiol often show enhanced pharmacological potency and selectivity. Although reversible Michael acceptors have been reported, the structural requirements for reversibility are poorly understood. Here, we report a novel class of acrylonitrile-based Michael acceptors, activated by aryl or heteroaryl electron-withdrawing groups. We demonstrate that thiol adducts of these acrylonitriles undergo β-elimination at rates that span more than 3 orders of magnitude. These rates correlate inversely with the computed proton affinity of the corresponding carbanions, enabling the intrinsic reversibility of the thiol-Michael reaction to be tuned in a predictable manner. We apply these principles to the design of new reversible covalent kinase inhibitors with improved properties. A cocrystal structure of one such inhibitor reveals specific noncovalent interactions between the 1,2,4-triazole activating group and the kinase. Our experimental and computational study enables the design of new Michael acceptors, expanding the palette of reversible, cysteine-targeted electrophiles.

Legend

Protein

Chemical

Disease

Primary Citation of related structures